Foster And Thrive Earwax Removal Kit Ear Wax Drops Kit
NDC Package 70677-1153-1
Package Information
Foster And Thrive Earwax Removal Kit Ear Wax Drops (carbamide peroxide) kits is a medication used to treat earwax buildup. This formulation utilizes a kit delivery system. Marketed by Mckesson Corp. Via Strategic Sourcing Services, this product is identified by NDC 70677-1153 and is authorized under FDA application M014.
Identification & Billing
- RxCUI: 702050 - carbamide peroxide 6.5 % Otic Solution
- RxCUI: 702050 - carbamide peroxide 65 MG/ML Otic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70677 - Mckesson Corp. Via Strategic Sourcing Services
- 70677-1153 - Foster And Thrive Earwax Removal Kit Ear Wax Drops
- 70677-1153-1 - 1 KIT in 1 KIT * 1 BOTTLE in 1 BOX (70677-1154-1) / 15 mL in 1 BOTTLE
- 70677-1153 - Foster And Thrive Earwax Removal Kit Ear Wax Drops
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70677-1153-1 identifies a specific commercial package of 1 kit in 1 kit * 1 bottle in 1 box (70677-1154-1) / 15 ml in 1 bottle of Foster And Thrive Earwax Removal Kit Ear Wax Drops, a human over the counter drug labeled by Mckesson Corp. Via Strategic Sourcing Services. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mckesson Corp. Via Strategic Sourcing Services on May 31, 2023. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat earwax buildup. It helps to soften, loosen, and remove the earwax. Too much earwax can block the ear canal and reduce hearing. This medication releases oxygen and starts to foam when it comes in contact with the skin. The foaming helps break up and remove the earwax. Consult your doctor before using this product in children younger than 12 years.
How is this Mckesson Corp. Via Strategic Sourcing Services product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70677115301. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.